A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)

Trial Profile

A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)

Not stated
Phase of Trial: Phase II

Latest Information Update: 10 Dec 2013

At a glance

  • Drugs Fondaparinux sodium; Heparin
  • Indications Thrombosis
  • Focus Therapeutic Use
  • Acronyms ASPIRE-Pilot
  • Sponsors Organon; Schering-Plough
  • Most Recent Events

    • 10 Dec 2013 Status changed from completed to unconfirmed.
    • 05 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top